Pas de connexion internet — affichage de la version enregistrée de la page.

Merck KGaA ADR

USUSD
← Vers le Screener

Merck KGaA ADR (MI:1MRKX) — Biotechnology: Pharmaceutical Preparations. Nombre de places boursières sur lesquelles les actions de la société sont cotées : 6. Sur cette page : cours et graphique, dividendes, principaux actionnaires et historique du nombre d'actions.

⚠ Ne les mélangez pas : il existe une autre entreprise avec le même nom ou un nom très similaire. C'est un enregistrement distinct — vérifiez le bourse, la bourse et le numéro d'enregistrement.
  • Merck KGaA — MRK · XETRA DE Numéro d'immatriculation inconnu

À propos de l'entreprise

Site Web
merck.com
Relations avec les Investisseurs
merck.com/investor-relations/
Secteur
Health Care · Biotechnology: Pharmaceutical Preparations
Siège Social
RAHWAY, Germany
PDG
Kai Beckmann
Employés
62 136
Cotée Depuis
22.11.2023 (MI:1MRKX)
Actions en Circulation
2.47 Md au 2026-07-31
Flottant
644.35 M
Capitalisation Boursière
67.93 Md USD
Initiés
0%
Investisseurs Institutionnels
0.02%
Secteur d'Activité (SIC)
Pharmaceutical Preparations
Forme Juridique
XSNP
ISIN
US58933Y1055
LEI
4YV9Y5M8S0BRK1RP0397
P/E
120
Taux de Distribution
262%
FCF
16.1 Md USD
Payout / FCF
52%
Dette
51.1 Md USD
2.8 ans de FCF
Ancienneté du Dividende
56+ ans
Bénéfices, FCF et dividendes versés — pour les 12 mois précédant 30.06.2026 (le dernier rapport de l'entreprise).
Description

Merck KGaA operates as a science and technology company in Europe, North America, Latin America, Middle East and Africa, and the Asia Pacific. The Life Science segment offers products, solutions, and services to academic, research and diagnostic labs, biotech, and pharmaceutical companies, as well as the industrial sector; reagents, consumables, devices, instruments, software, and services for research, production, and testing to lab water instruments, microbiology and biomonitoring products, test assays, analytical reagents, and flow cytometry kits and instruments. This segment also provides traditional and novel therapies, such as ration devices, chromatography resins, single-use systems, process chemicals, and excipients for bioprocessing; contract development, manufacturing and testing services, which supports customers from preclinical phases to commercialization. The Healthcare segment discovers, develops, manufactures, and markets prescription drugs and biopharmaceuticals to the therapeutic areas of oncology, rare diseases, neurology and immunology, fertility, cardiovascular, and metabolic and endocrinological disorders. The Electronics segment offers advanced dielectric and metallic materials; photoresist, anti-reflective coating, and material lithography products; clean and selective etch chemistries; materials for chemical-mechanical planarization; high-purity gases for semiconductor manufacturing; and develops and installs delivery equipment for handling of specialty chemicals and gases for semiconductor manufacturing; develops modulating, creating, engineering, and guiding light; and material solutions in liquid crystals, OLED materials, and photoresists. It has in-licensing agreement with Abbisko Therapeutics Co. Ltd., China on drug candidates for the treatment of tenosynovial giant cell tumor; and strategic partnership with Versant Ventures to advance treatments for rare genetic cardiomyopathies. The company was founded in 1668 and is headquartered in Darmstadt, Germany. Merck KGaA operates as a subsidiary of E. Merck KG.

publicité

Bourses et Tickers

BourseTickerDevisePrixType
US USA StocksMRK secondaireUSD145.6 +2.26%actions ordinaires
LSE London Stock Exchange0QAH IOBUSD148.65 -0.12%actions ordinaires
MI Borsa Italiana (Milan)1MRKX principaleEUR129.62 -0.37%actions ordinaires
MX Mexican Stock ExchangeMRK secondaireMXN2 690 +6.68%actions ordinaires
VI Vienna Stock ExchangeMRK secondaireEUR124.84 -2.79%actions ordinaires
XETRA Xetra6MK secondaireEUR129.78 +0.09%actions ordinaires

Cours sur 3 Mois

jour de hausse jour de baisse date de détachement du dividende date de versementSurvolez / touchez un jour — cours d'ouverture, de clôture, plus haut et plus bas

Dividendes

Par an, MI:1MRKX: 3.0202 EUR (4 vers.)

Merck KGaA ADR (1MRKX) verse des dividendes trimestriels. Par an (12 mois jusqu'au dernier paiement annoncé inclus) : 3.0202 EUR par action (paiements : 4). Cela représente environ 2.33% du cours actuel de l'action. D'après l'historique des paiements, la prochaine date ex-dividende est prévue vers 15.12.2026. Historique des dividendes ininterrompu : 56 ans.

Date ExVersementMontant%TypeTicker
2026-09-15—0.7551 EUR0.6/2.4 %trimestrielMI:1MRKX
2026-06-15—0.7551 EUR0.7/2.8 %trimestrielMI:1MRKX
2026-03-16—0.7551 EUR0.8/2.9 %trimestrielMI:1MRKX
2025-12-15—0.7551 EUR0.9/3.4 %trimestrielMI:1MRKX
2025-09-15—0.7195 EUR1.0/4.0 %trimestrielMI:1MRKX
2025-06-16—0.7195 EUR1.0/4.0 %trimestrielMI:1MRKX
2025-03-17—0.7195 EUR0.8/3.3 %trimestrielMI:1MRKX
2024-12-16—0.7195 EUR0.7/2.9 %trimestrielMI:1MRKX
2024-09-16—0.6840 EUR0.7/2.6 %trimestrielMI:1MRKX
2024-06-17—0.6840 EUR0.6/1.7 %trimestrielMI:1MRKX
2024-03-14—0.6840 EUR0.6/1.2 %trimestrielMI:1MRKX
2023-12-14—0.6840 EUR0.7/0.7 %trimestrielMI:1MRKX

Principaux Actionnaires

DétenteurParticipationActionsDate du Rapport
BlackRock9.2%227 M2026-06-30
Vanguard Capital Managem…6.54%161.32 M2026-06-30
State Street Corporation4.88%120.41 M2026-06-30
Wellington Management Gr…3.5%86.25 M2026-06-30
VANGUARD INDEX FUNDS-Van…3.18%78.41 M2026-06-30
Vanguard Portfolio Manag…2.75%67.74 M2026-06-30
VANGUARD INDEX FUNDS-Van…2.59%64 M2026-06-30
Geode Capital Management…2.46%60.74 M2026-06-30
Charles Schwab Investmen…2.2%54.37 M2026-06-30
Morgan Stanley1.97%48.64 M2026-06-30
FMR, LLC1.84%45.44 M2026-06-30
JPMORGAN CHASE & CO1.78%43.89 M2026-06-30
iShares Trust-iShares Co…1.33%32.89 M2026-08-31
Fidelity Concord Street…1.29%31.94 M2026-07-31
SCHWAB STRATEGIC TRUST-S…1.25%30.86 M2026-05-31
SPDR S&P 500 ETF TRUST-S…1.22%30.22 M2026-08-31
VANGUARD INDEX FUNDS-Van…0.95%23.51 M2026-06-30
SELECT SECTOR SPDR TRT-S…0.72%17.75 M2026-08-31
VANGUARD SPECIALIZED FUN…0.65%15.95 M2026-07-31
VANGUARD SPECIALIZED FUN…0.57%13.97 M2026-07-31
DAVIS ROBERT M (Chief Ex…≈0.02%450 3512026-04-29
CHATTOPADHYAY SANAT (Off…≈0.01%200 6752026-04-29
DELUCA RICHARD ROBERT JR…≈0%110 1672026-08-12
LI DEAN Y (Officer)≈0%94 4312026-04-29
LITCHFIELD CAROLINE (Chi…≈0%92 3002026-04-29
ZACHARY JENNIFER L (Gene…≈0%45 5092026-08-12
GUINDO CHIRFI (Officer)≈0%36 6132026-08-13
WILLIAMS DAVID MICHAEL (…≈0%31 7162026-08-05
ROMANELLI JOSEPH EDWARD…≈0%28 7392026-01-26
OOSTHUIZEN JOHANNES JACO…≈0%21 8952026-04-29
Trust for Professional M…0%24 8032026-05-31
Rhumbline Advisers0%10 9192026-06-30
SP Funds Trust-SP Funds…0%6 5422026-07-31
Atlas Capital Advisors I…0%2 4672026-06-30
Gamma Investing LLC0%2 3022026-06-30
Salomon & Ludwin, LLC0%3562026-06-30
PNC Financial Services G…0%22026-06-30
The Vanguard Group———